Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1987 4
1988 10
1989 10
1990 11
1991 9
1992 18
1993 12
1994 14
1995 16
1996 17
1997 16
1998 16
1999 14
2000 20
2001 18
2002 33
2003 31
2004 35
2005 22
2006 26
2007 28
2008 20
2009 22
2010 8
2011 6
2012 9
2013 18
2014 12
2015 5
2016 7
2017 10
2018 7
2019 6
2020 7
2021 3
2022 3
2023 1
2024 5
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

511 results

Results by year

Filters applied: . Clear all
Page 1
Ginger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trial.
Yamprasert R, Chanvimalueng W, Mukkasombut N, Itharat A. Yamprasert R, et al. BMC Complement Med Ther. 2020 Apr 20;20(1):119. doi: 10.1186/s12906-020-2875-z. BMC Complement Med Ther. 2020. PMID: 32312261 Free PMC article. Clinical Trial.
This study was designed to assess efficacy and safety of ginger extract in comparison with loratadine for AR treatment. METHODS: AR patients were treated with ginger extract 500 mg (n = 40) against those treated with loratadine 10 mg (n = 40) in a randomized, double …
This study was designed to assess efficacy and safety of ginger extract in comparison with loratadine for AR treatment. METHODS: AR p …
Efficacy and safety of combined loratadine and mometasone furoate therapy in allergic rhinitis patients.
Yong H, Di L, Wang Z, Yang J, Yang P, Gao X. Yong H, et al. Front Immunol. 2025 Jun 4;16:1560295. doi: 10.3389/fimmu.2025.1560295. eCollection 2025. Front Immunol. 2025. PMID: 40534872 Free PMC article. Clinical Trial.
OBJECTIVE: This study seeks to assess the effectiveness and safety of a combination treatment involving loratadine and mometasone furoate for patients suffering from allergic rhinitis (AR). Additionally, it explores the risk factors contributing to treatment failure, provi …
OBJECTIVE: This study seeks to assess the effectiveness and safety of a combination treatment involving loratadine and mometasone fur …
Brompheniramine, loratadine, and placebo in allergic rhinitis: a placebo-controlled comparative clinical trial.
Druce HM, Thoden WR, Mure P, Furey SA, Lockhart EA, Xie T, Galant S, Prenner BM, Weinstein S, Ziering R, Brandon ML. Druce HM, et al. J Clin Pharmacol. 1998 Apr;38(4):382-9. doi: 10.1002/j.1552-4604.1998.tb04439.x. J Clin Pharmacol. 1998. PMID: 9590467 Clinical Trial.
Loratadine was significantly better than placebo for physician ratings of total symptom severity averaged over the two days and for the physician and subject ratings of the nasal cluster on day 3. ...A nonprescription, extended-release formulation of brompheniramine 12 mg …
Loratadine was significantly better than placebo for physician ratings of total symptom severity averaged over the two days and for t …
Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF. Meltzer EO, et al. J Allergy Clin Immunol. 2000 May;105(5):917-22. doi: 10.1067/mai.2000.106040. J Allergy Clin Immunol. 2000. PMID: 10808172 Clinical Trial.
RESULTS: Concomitant montelukast with loratadine improved the primary end point significantly (P <.001) compared with placebo and each agent alone. ...Montelukast alone and loratadine alone caused modest improvements in rhinitis end points. All treatments were si …
RESULTS: Concomitant montelukast with loratadine improved the primary end point significantly (P <.001) compared with placebo and …
Sedative effects of antihistamines.
Roth T, Roehrs T, Koshorek G, Sicklesteel J, Zorick F. Roth T, et al. J Allergy Clin Immunol. 1987 Jul;80(1):94-8. doi: 10.1016/s0091-6749(87)80197-5. J Allergy Clin Immunol. 1987. PMID: 2885356 Clinical Trial.
Diphenhydramine was administered in three equal doses (50 mg), and loratadine was administered in a single dose followed by two placebo doses. Mean latency to sleep on tests done at 9 and 11 A.M. and 1, 3, and 5 P.M. was reduced significantly with diphenhydramine compared …
Diphenhydramine was administered in three equal doses (50 mg), and loratadine was administered in a single dose followed by two place …
Loratadine augments emotional blushing.
Drummond PD, Lester B. Drummond PD, et al. Eur Neuropsychopharmacol. 2018 Nov;28(11):1284-1288. doi: 10.1016/j.euroneuro.2018.08.003. Epub 2018 Aug 26. Eur Neuropsychopharmacol. 2018. PMID: 30153954 Clinical Trial.
The aim of this study was to determine whether loratadine, a selective inverse agonist of peripheral histamine H(1) receptors, would reduce emotional blushing. ...Increases in facial blood flow while participants sang were greater in the loratadine than the placebo …
The aim of this study was to determine whether loratadine, a selective inverse agonist of peripheral histamine H(1) receptors, would …
Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.
Lu S, Malice MP, Dass SB, Reiss TF. Lu S, et al. J Asthma. 2009 Nov;46(9):878-83. doi: 10.3109/02770900903104540. J Asthma. 2009. PMID: 19905912 Clinical Trial.
OBJECTIVE: We compared the efficacy of this combination versus placebo, nasal beclomethasone, montelukast, and loratadine in study 1 and versus placebo, montelukast, and loratadine in study 2. METHODS: Patients were randomly allocated to double-blind treatment with …
OBJECTIVE: We compared the efficacy of this combination versus placebo, nasal beclomethasone, montelukast, and loratadine in study 1 …
Clinical pharmacology of the H1-receptor antagonists cetirizine and loratadine in children.
Simons FE, Johnston L, Simons KJ. Simons FE, et al. Pediatr Allergy Immunol. 2000 May;11(2):116-9. doi: 10.1034/j.1399-3038.2000.00045.x. Pediatr Allergy Immunol. 2000. PMID: 10893015 Clinical Trial.
Our objective was to determine the onset and duration of action and the relative potency of the H1-receptor antagonists cetirizine and loratadine in children. We performed a prospective, randomized, placebo-controlled, double-blind, crossover, single-dose study of cetirizi …
Our objective was to determine the onset and duration of action and the relative potency of the H1-receptor antagonists cetirizine and lo …
511 results